WILLIAM WILLIAMS: Open Payments
NPI 1093814949 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 51 payments from 11 companies in 2025. Trend: 2023 $872 · 2024 $954 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $280 |
| ABBVIE INC. | 24 | $174 |
| Corcept Therapeutics | 3 | $126 |
| Novartis Pharmaceuticals Corporation | 6 | $98 |
| PFIZER INC. | 3 | $44 |
| Lilly USA, LLC | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: Wegovy, Korlym, LEQVIO, UBRELVY, VRAYLAR, NURTEC ODT, CREON, Kerendia.
Industry payments across TX — which companies pay providers there.
